1887

Chapter 14 : Enteroviral Myocarditis and Dilated Cardiomyopathy: a Review of Clinical and Experimental Studies

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

Enteroviral Myocarditis and Dilated Cardiomyopathy: a Review of Clinical and Experimental Studies, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818326/9781555810924_Chap14-1.gif /docserver/preview/fulltext/10.1128/9781555818326/9781555810924_Chap14-2.gif

Abstract:

This chapter presents epidemiologic data on the incidence of myocarditis and dilated cardiomyopathy (DCM) and their associations with enteroviruses. The pathogenesis of enterovirus-induced heart disease is comprehensively reviewed, with particular attention given to experimental studies elucidating the viral and immunologic mechanisms of the disease process. The chapter gives an overview of pathology, and talks about viral replication in the heart, host defense mechanisms, cell-mediated destruction of myofibers, virus participation in chronic heart disease, autoimmunity, viral infection and cardiac dysfunction, and factors affecting disease severity. Next, it reviews the detection of enteroviral infection in patients with myocarditis and DCM. It also describes the clinical features of myocarditis and DCM, and discusses evidence that these diseases are two ends of the same disease spectrum. Finally, the chapter reviews conventional treatments for patients with myocarditis and DCM. In addition, the role of immunosuppression and future avenues of therapy are also examined.

Citation: Martino T, Liu P, Sole M, Petric M. 1995. Enteroviral Myocarditis and Dilated Cardiomyopathy: a Review of Clinical and Experimental Studies, p 291-351. In Rotbart H (ed), Human Enterovirus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818326.ch14

Key Concept Ranking

Coronary Artery Disease
0.49323854
Theiler's Murine Encephalomyelitis
0.4204164
Herpes simplex virus 1
0.412244
0.49323854
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Transverse cross-sectional slice of representative heart from virus-infected mice. Note the multifocal nature of the myocardial lesions, which consist of necrotic myocardial cells and an inflammatory cell infiltrate. Hematoxylin and eosin stain. Magnification, Xl5. Reproduced from the Journal of Clinical Investigation ( ), by copyright permission of the American Society for Clinical Investigation.

Citation: Martino T, Liu P, Sole M, Petric M. 1995. Enteroviral Myocarditis and Dilated Cardiomyopathy: a Review of Clinical and Experimental Studies, p 291-351. In Rotbart H (ed), Human Enterovirus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818326.ch14
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

Light microscopic sections of representative murine hearts. (A) Pathologic changes in CVB3 murine myocarditis. Note the massive myocardial necrosis and inflammatory cell infiltrate in the ventricular myocardium of an A/J mouse at day 7 postinfection. (B) Control heart from an uninfected age-matched mouse. Hematoxylin and eosin stain. Magnification, X40.

Citation: Martino T, Liu P, Sole M, Petric M. 1995. Enteroviral Myocarditis and Dilated Cardiomyopathy: a Review of Clinical and Experimental Studies, p 291-351. In Rotbart H (ed), Human Enterovirus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818326.ch14
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 3
FIGURE 3

Microvascular perfusion from thick sections. Microfil (liquid silicone rubber) was perfused to cast the coronary vessels. (A) Control (verapamil treated) on day 14, with many smooth vessels. (B) Virus-infected heart on day 14. Vessels show multiple focal areas of constriction and narrowing. Magnification, Xl00. The photograph was kindly contributed to our laboratory by Fayez Dawood and Wen-Hu Wen.

Citation: Martino T, Liu P, Sole M, Petric M. 1995. Enteroviral Myocarditis and Dilated Cardiomyopathy: a Review of Clinical and Experimental Studies, p 291-351. In Rotbart H (ed), Human Enterovirus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818326.ch14
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 4
FIGURE 4

Proposed mechanisms involved in the pathogenesis of DCM following viral myocarditis. Reprinted with permission from the American College of Cardiology ( ).

Citation: Martino T, Liu P, Sole M, Petric M. 1995. Enteroviral Myocarditis and Dilated Cardiomyopathy: a Review of Clinical and Experimental Studies, p 291-351. In Rotbart H (ed), Human Enterovirus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818326.ch14
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555818326.chap14
1. Abelmann, W. H. 1971. Virus and the heart. Circulation 44:950956.
2. Abelmann, W. H. 1984. Classification and natural history of primary myocardial disease. Prog. Cardiovasc. Dis. 27:7394.
3. Abelmann, W. H. 1985. Incidence of dilated cardiomyopathy. Postgrad. Med. J. 61:11231124.
4. Abelmann, W. H., 1988. Etiology, pathogenesis, and pathophysiology of dilated cardiomyopathy, p. 322. Jit H.-P. Schultheiss (ed.), New Concepts in Viral Heart Disease. Springer-Verlag, Berlin.
5. Abzug, M. J.,, H. A. Rotbart,, and M. J. Levin. 1989. Demonstration of a barrier to transplacental passage of murine enteroviruses in late gestation. J. Infect. Dis. 159:761765.
6. Abzug, M. J.,, H. A. Rotbart,, S. A. Magliato,, and M. J. Levin. 1991. Evolution of the placental barrier to fetal infection by murine enteroviruses. J. Infect. Dis. 163:13361341.
7. Ahmed, R.,, L. D. Butler,, and L. Bhatti. 1988. T4+ T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses. J. Virol. 62:21022106.
8. Akinkugbe, O. O.,, G. D. Nicholson,, and J. K. Cruickshank. 1991. Heart disease in blacks of Africa and the Caribbean. Cardiovasc. Clin. 2(3):377391.
9. Anderson, J. L.,, J. F. Carlquist,, and E. H. Hammond. 1982. Deficient natural killer cell activity in patients with idiopathic dilated cardiomyopathy. Lancet ii:11241127.
10. Anderson, J. L.,, J. F. Carlquist,, J. R. Lutz,, C. W. DeWitt,, and E. H. Hammond. 1984. HLA A, B and DR typing in idiopathic dilated cardiomyopathy: a search for immune response factors. Am. J. Cardiol. 53:13261330.
11. Arai, K.,, F. Lee,, A. Miyajima,, S. Miyatake,, N. Arai,, and T. Yokota. 1990. Cytokines: coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 59:783836.
12. Archard, L. C.,, N. E. Bowles,, L. Cunningham,, C. A. Freeke,, E. G. J. Olsen,, M. L. Rose,, B. Meany,, H. J. F. Why,, and P. J. Richardson. 1991. Molecular probes for detection of persisting enterovirus infection of human heart and their prognostic value. Eur. Heart J. Suppl. D 12:5659.
13. Archard, L. C.,, N. E. Bowles,, E. G. J. Olsen,, and P. J. Richardson. 1987. Detection of persistent coxsackie B virus RNA in dilated cardiomyopathy and myocarditis. Eur. Heart J. Suppl. J 8:437440.
14. Aretz, H. T. 1987. Myocarditis: the Dallas criteria. Hum. Pathol. 18:619624.
15. Aretz, H. T.,, M. E. Billingham,, W. D. Edwards,, S. M. Factor,, J. T. Fallon,, J. J. Fenoglio Jr.,, E. G. J. Olsen,, and F. J. Schoen. 1987. Myocarditis. A histopathologic definition and classification. Am. J. Cardiovasc. Pathol. 1:314.
16. Argo, E.,, B. Gimenez,, and P. Cash. 1992. Non-cytopathic infection of rhabdomyosarcoma cells by coxsackie B5 virus. Arch. Virol. 126:215229.
17. Bagger, J. P.,, U. Baandrup,, K. Rasmussen,, M. Moeller,, and T. Vesterlund. 1984. Cardiomyopathy in western Denmark. Br. Heart J. 52:327331.
18. Baker, D. A.,, and C. A. Phillips. 1980. Maternal and neonatal infection with coxsackievirus. Obstet. Gynecol. 55(Suppl.):12S15S.
18a. Ballingand, J.-L.,, R. A. Kelly,, P. A. Marsden,, T. W. Smith,, and T. Michel. 1993. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc. Natl. Acad. Sci. USA 90:347351.
18b. Balligand, J.-L.,, D. Ungureanu,, R. A. Kelly,, L. Kobzik,, D. Pimental,, T. Michel,, and T. W. Smith. 1993. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J. Clin. Invest. 91:23142319.
18c. Balligand, J.-L.,, D. Ungureanu,, D. Pimental,, R. A. Kelly,, T. W. Smith,, and T. Michel. 1993. Detection of transcripts for a cytokine inducible nitric oxide synthase isoform in adult rat ventricular myocytes. Circulation 88:1384.
19. Bandt, C. M.,, N. A. Staley,, and G. R. Noren. 1979. Acute viral myocarditis: clinical and histologic changes. Minn. Med. 62:234237.
20. Beck, M. A.,, N. M. Chapman,, B. M. McManus,, J. C. Mullican,, and S. Tracy. 1990. Secondary enterovirus infection in the murine model of myocarditis. Am. J. Pathol. 136:669681.
21. Beck, M. A.,, P. C. Kolbeck,, L. H. Rohr,, Q. Shi,, V. C. Morris,, and O. A. Levander. 1994. Vitamin E deficiency intensifies the myocardial injury of coxsackievirus B3 infection of mice. J. Nutr. 124:345358.
22. Beck, M. A.,, and S. M. Tracy. 1989. Murine cell-mediated immune response recognizes an enterovirus group-specific antigen(s). J. Virol. 63:41484156.
23. Beisel, K.W.,, J. Srinivasappa,, M. R. Olsen,, A. C. Stiff,, K. Essani,, and B. S. Prabhakar. 1990. A neutralizing monoclonal antibody against coxsackievirus B4 cross-reacts with contractile muscle proteins. Microb. Pathog. 8:151156.
24. Beisel, K. W.,, J. Srinivasappa,, and B. S. Prabhakar. 1991. Identification of a putative shared epitope between coxsackie virus B4 and alpha cardiac myosin heavy chain. Clin. Exp. Immunol. 86:4955.
25. Beisel, K. W.,, J. Srinivasappa,, and B. S. Prabhakar. 1991. Molecular cloning of a heart antigen that cross-reacts with a neutralizing antibody to coxsackievirus B4. Eur. Heart J. Suppl. D 12:6064.
26. Bendinelli, M.,, D. Matteucci,, P. G. Conaldi,, A. M. Giangregorio,, M. R. Capobianchi,, and F. Dianzani. 1987. Mechanisms of group B coxsackie virus persistence in human cells. Eur. Heart J. Suppl. J 8:441444.
27. Bengtsson, E.,, and B. Lamberger. 1966. Five-year follow-up study of cases suggestive of acute myocarditis. Am. Heart J. 72:751763.
28. Bergelson, J. M.,, M. P. Shepley,, B. M. C. Chan,, M. E. Hemler,, and R. W. Finberg. 1992. Identification of the integrin VLA-2 as a receptor for echovirus 1. Science 255:17181720.
29. Bergstrom, K.,, U. Erikson,, F. Nordbring,, B. Nordgren,, and A. Parrow. 1970. Acute non-rheumatic myopericarditis: a follow-up study. Scand. J. Infect. Dis. 2:716.
30. Billingham, M. E. 1989. Myocarditis and endomyocardial biopsy. Ann. Intern. Med. 110:165166.
31. Blacklow, N. R.,, F. B. Rose,, and R. A. Whalen. 1975. Organ culture of human aorta: prolonged survival with support of viral replication. J. Infect. Dis. 131:575578.
32. Blay, R.,, K. Simpson,, K. Leslie,, and S. A. Huber. 1989. Coxsackievirus-induced disease. CD4+ cell initiate both myocarditis and pancreatitis in DBA/2 mice. Am. f. Pathol. 135:899907.
33. Boring, W. D.,, G. M. ZuRhein,, and D. L. Walker. 1956. Factors influencing host-virus interactions. II. Alteration of coxsackie virus infection in adult mice by cold. Proc. Soc. Exp. Biol. Med. 93:273277.
34. Bowles, N. E.,, P. J. Richardson,, E. G. J. Olsen,, and L. C. Archard. 1986. Detection of coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet i:11201123.
35. Bowles, N. E.,, M. L. Rose,, P. Taylor,, N. R. Banner,, P. Morgan-Capner,, L. Cunningham,, L. C. Archard,, and M. H. Yacoub. 1989. End-stage dilated cardiomyopathy. Persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation 80:11281136.
36. Burch, G. E.,, S. C. Sun,, H. L. Colcolough,, R. S. Sohal,, and N. P. DePasquale. 1967. Coxsackie B viral myocarditis and valvulitis identified in routine autopsy specimens by immunoflourescent techniques. Am. Heart J. 74:1323.
37. Byrne, J. A.,, and M. B. A. Oldstone. 1984. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J. Virol. 51:682686.
38. Cafario, A. L. P.,, E. Bonifacio,, J. T. Stewart,, D. Neglia,, O. Parodi,, G. F. Bottazzo,, and W. J. McKenna. 1990. Novel organ-specific circulating autoantibodies in dilated cardiomyopathy. J. Am. Coll. Cardiol. 15:15271534.
39. Cambridge, C.,, C. G. C. MacArthur,, A. P. Waterson,, J. F. Goodwin,, and C. M. Oakley. 1979. Antibodies to coxsackie B viruses in congestive cardiomyopathy. Br. Heart J. 41:692696.
40. Carlquist, J. R.,, R. L. Menlove,, M. B. Murray,, J. B. O'Connell,, and J. L. Anderson. 1991. HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Validation study and metaanalysis of published HLA association studies. Circulation 83:515522.
41. Carrio, I.,, L. Berna,, M. Ballester,, M. Estorch,, D. Obrador,, M. Cladellas,, L. Abadal,, and M. Ginjaume. 1988. Indium-Ill antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection. J. Nucl. Med. 29:18931900.
42. Casans, I.,, A. Villar,, V. Almenar,, and A. Blanes. 1989. Lyme myocarditis diagnosed by indium-Ill antimyosin scintigraphy. Eur.J. Nucl. Med. 15:330331.
43. Chandraranta, R. A.,, W. G. Bradley,, K. E. Korman,, S. Minagoe,, M. Delvicario,, and S. H. Rahimtoola. 1987. Detection of acute myocarditis using nuclear magnetic resonance imaging. Am. J. Med. 83:11441146.
44. Cheever, F. S. 1953. Multiplication of coxsackie virus in adult mice exposed to Roentgen radiation. J. Immunol. 71:431435.
45. Cherry, J. D., 1990. Enteroviruses, p. 325366. In J. S. Remington, and J. O. Klein (ed.), Infectious Diseases of the Fetus and Newborn Infant. The W. B. Saunders Co., Philadelphia.
46. Cho, C. T.,, K. K. Feng,, V. R McCarthy,, and M. F. Lenahan. 1982. Role of antiviral antibodies in resistance against coxsackievirus B3 infection: interaction between preexisiting antibodies and an interferon inducer. Infect. Immun. 37:720727.
47. Chow, L. H.,, K. W. Beisel,, and B. M. McManus. 1992. Enteroviral infection of mice with severe combined immunodeficiency: evidence for direct viral pathogenesis of myocardial injury. Lab. Invest. 66:2431.
48. Chow, L. H.,, C. J. Gauntt,, and B. M. McManus. 1991. Differential effects of myocarditic variants of coxsackievirus B3 in inbred mice. A pathological characterization of heart tissue damage. Lab. Invest. 64:5564.
49. Chow, L. H.,, S. J. Radio,, T. D. Sears,, and B. M. McManus. 1989. Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. J. Am. Coll. Cardiol. 14:915920.
50. Codd, M. B.,, D. D. Sugrue,, B. J. Gersh,, and L. J. Melton. 1989. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. Circulation 80:564572.
51. Correa, P.,, C. Restrepo,, C. Garcia,, and A. C. Quiroz. 1963. Pathology of heart disease of undetermined etiology which occur in Cali, Colombia. Am. Heart J. 66:584596.
52. Costanzo-Nordin, M. R.,, E. A. Reap,, J. B. O'Connell,, J. A. Robinson,, and P. J. Scanlon. 1985. A nonsteroid anti-inflammatory drug exacerbates coxsackie B3 murine myocarditis. J. Am. Coll. Cardiol. 6:10781082.
53. Craighead, J. E.,, S. A. Huber,, and S. Sriram. 1990. Biology of disease. Animal models of picornavirus-induced autoimmune disease: their possible relevance to human disease. Lab. Invest. 63:432446.
54. Cronin, M. E.,, L. A. Love,, F. W. Miller,, P. R. McClintock,, and P. H. Plotz. 1988. The natural history of encephalomyocarditis virus-induced myositis and myocarditis in mice. Viral persistence demonstrated by in situ hybridization. J. Exp. Med. 168:16391648.
55. Crowell, R. L. 1963. Specific viral interference in HeLa cell cultures chronically infected with coxsackie B5 virus. J. Bacteriol. 86:517526.
56. Crowell, R. L.,, A. K. Field,, W. A. Schleif,, W. L. Long,, R. J. Colonno,, J. E. Mapoles,, and E. A. Emini. 1986. Monoclonal antibody that inhibits infection of HeLa and rhabdomyosarcoma cells by selected enteroviruses through receptor blockade. J. Virol. 57:438445.
57. Cunningham, M. W.,, S. M. Antone,, J. M. Gulizia,, B. M. McManus,, V. A. Fischetti,, and C. J. Gauntt. 1992. Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin. Proc. Natl. Acad. Sci. USA 89:13201324.
58. Cunningham, M. W.,, S. M. Antone,, J. M. Gulizia,, B. A. McManus,, and C. J. Gauntt. 1993. (3-Helical coiled-coil molecules: a role in autoimmunity against the heart. Clin. Immunol. Immunopathol. 68:118123.
59. DaUdorf, G.,, and R. Gifford. 1954. Susceptibility of gravid mice to coxsackie virus infection.}. Exp. Med. 99:2127.
60. Dalldorf, G.,, and J. L. Melnick,. 1965. Coxsackie viruses, p. 474512. In F. L. Horsfall, Jr.,, and I. Tamm (ed.), Viral and Rickettsial Infections of Man, 4th ed. L. B. Lippincott Co., Philadelphia.
61. De Belder, A. J.,, M. W. Radomski,, H. J. F. Why,, P. J. Richardson,, C. A. Bucknall,, E. Salas,, J. F. Martin,, and S. Moncada. 1993. Nitric oxide synthase activities in human myocardium. Lancet 341:8485.
62. Dec, W. G.,, I. Palacios,, T. Yasuda,, J. T. Fallon,, B. A. Khaw,, H. W. Strauss,, and E. Haber. 1990. Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis. J.Am. Coll. Cardiol. 16:97104.
63. De Clerco, E.,, J. Murase,, and V. E. Marquez. 1991. Broad-spectrum antiviral and cytocidal activity of cyclopentenylcytosine, a carbocyclic nucleoside targeted at CTP synthetase. Biochem. Pharmacol. 41:18211829.
64. de la Torre, J. C.,, M. Davila,, F. Sobrino,, J. Ortin,, and E. Domingo. 1985. Establishment of cell lines persistently infected with foot-and-mouth disease virus. Virology 145:2435.
65. Demakis, J. G.,, and S. H. Rahimtoola. 1971. Peripartum cardiomyopathy. Circulation 44:964968.
66. De Maria, R.,, A. Gavazzi,, F. Recalcati,, G. Baroldi,, C. De Vita,, and F. Camerini. 1993. Comparison of clinical findings in idiopathic dilated cardiomyopathy in women versus men. Am. J. Cardiol. 72:580585.
67. De Ward, M.J. D. 1992. How can myocarditis be diagnosed and should it be treated? Br. Heart J. 68:346347 (Editorial).
68. Dianzani, F.,, M. R. Capobianchi,, D. Matteucci,, and M. Bendinelli,. 1988. The role of interferon in picornavirus infections, p. 6580. In M. Bendinelli and H. Friedman (ed.), Coxsackieviruses: a General Update. Plenum Press, New York.
69. Doherty, P. C.,, W. Allen,, and M. Eichelberger. 1992. Roles of dp" and y8T cell subsets in viral immunity. Annu. Rev. Immunol. 10:123151.
70. Dong, R.,, P. Liu,, L. Wee,, J. Butany,, and M.J. Sole. 1992. Verapamil ameliorates the clinical and pathological course of murine myocarditis. J. Clin. Invest. 90:20222030.
71. Drude, L.,, F. Wiemers,, and B. Maisch. 1991. Impaired myocyte function in vitro incubated with sera from patients with myocarditis. Eur. Heart J. Suppl. D 12:3638.
72. Easton, A. J.,, and R. P. Eglin. 1988. The detection of coxsackievirus RNA in cardiac tissue by in situ hybridization. J. Gen. Virol. 69:285291.
73. Eckstein, R.,, W. Mempel,, and H.-D. Bolte. 1982. Reduced suppressor cell activity in congestive cardiomyopathy and myocarditis. Circulation 65:12241229.
74. El-Hagrassy, M. M. O.,, and J. E. Banatvala. 1980. Coxsackie-B-virus-specific IgM responses in patients with cardiac and other diseases. Lancet ii:11601162.
75. Ertl, G.,, B. Bauer,, S. Neubauer,, W. Schorb,, and K. Kochsiek. 1991. Effect of mediators on coronary circulation. Eur. Heart J. Suppl. D 12:187189.
76. Estrin, M.,, M. Herzum,, C. Buie,, and S. A. Huber. 1987. Immunosuppressives in murine myocarditis. Eur. Heart J. Suppl. J 8:259262.
77. Estrin, M.,, and S. A. Huber. 1987. Coxsackievirus B3 induced myocarditis: autoimmunity is L3T4+ T helper cell and IL-2 independent in Balb/c mice. Am. J. Pathol. 127:335341.
78. Factor, S. M.,, T. Minase,, S. Cho., R. Dominitz, and E. H. Sonnenblick. 1982. Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis. Circulation 66:342354.
79. Factor, S. M.,, H. Tanowitz,, M. Wittner,, and M. C. Ventura. 1993. Interstitial connective tissue matrix alterations in acute murine Chagas' disease. Clin. Immunol. Immunopathol. 68:147152.
80. Farrar, M. A.,, and R. D. Schreiber. 1993. The molecular cell biology of interferon-g and its receptor. Annu. Rev. Immunol. 11:571611.
81. Federici, E. E.,, A. M. Lerner,, and W. H. Abelmann. 1963. Observations on the course of coxsackie A-9 myocarditis in C3H mice. Proc. Soc. Exp. Biol. Med. 112:672676.
82. Felix, J. C.,, B. F. von Kreuter,, and C. A. Santos-Buch. 1993. Mimicry of heart cell surface epitopes in primary anti-trypanosoma cruzi Lyt 2+ T lymphocytes. Clin. Immunol. Immunopathol. 68:141146.
83. Finkel, M. S.,, C. V. Oddis,, T. D. Jacob,, S. C. Watkins,, B. G. Hattler,, and R. L. Simmons. 1992. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257:387389.
84. Fohlman, J.,, N.-G. Dback,, G. Friman,, and B. Morein. 1990. Vaccination of Balb/c mice against enteroviral mediated myocarditis. Vaccine 8:381384.
85. Fohlman, J.,, K. Pauksen,, B. Morein,, U. Bjare,, N.-G. Dback,, and G. Friman. 1993. High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis. Scand. J. Infect. Dis. Suppl. 88:103108.
86. Foulis, A. K.,, M. A. Farquharson,, S. O. Cameron,, M. McGill,, H. Schonke,, and R. Kandolf. 1990. A search for the presence of the enteroviral capsid protein VP 1 in pancreases of patients with type 1 (insulin-dependent) diabetes and pancreases and hearts of infants who died of coxsackieviral myocarditis. Diabetologia 33:290298.
87. Fowles, R. E.,, C. P. Bieber,, and E. B. Stinson. 1979. Defective in vitro suppressor cell function in idiopathic congestive cardiomyopathy. Circulation 59:483491.
88. Frank, J. A.,, E. V. Shmidt,, R. E. Smith,, and C. M. Wilfert. 1986. Persistent infection of rat insulinoma cells with coxsackie B4 virus. Arch. Virol. 87:143150.
89. Friman, G.,, and J. Fohlman. 1993. The epidemiology of viral heart disease. Scand. J. Infect. Dis. Suppl. 88:710.
90. Frizelle, S.,, J. Schwarz,, S. A. Huber,, and K. Leslie. 1992. Evaluation of the effects of low molecular weight heparin on inflammation and collagen deposition in chronic coxsackievirus B3-induced myocarditis in A/J mice. Am. J. Pathol. 141:203209.
91. Fujii, Y.,, F. Sendo,, T. Kamiyama,, and M. Naiki. 1990. IgG antibodies to asialo GM1 are more sensitive than IgM antibodies to kill in vivo natural killer cells and premature cytotoxic T lymphocytes of mouse spleen. Microbiol. Immunol. 34:533542.
92. Fuster, V.,, B. J. Gersh,, E. R. Giuliani,, A. J. Tajik,, R. O. Brandenburg,, and R. L. Frye. 1981. The natural history of idiopathic dilated cardiomyopathy. Am. J. Cardiol. 47:525531.
93. Gagliardi, M. G.,, M. Bevilacqua,, R. Di Renzi,, S. Picardo,, R. Passariello,, and C. Marcelletti. 1991. Usefulness of magnetic resonance imaging for diagnosis of acute myocarditis in infants and children, and comparison with endomyocardial biopsy. Am. J. Cardiol. 68:10891091.
94. Gatmaitan, B. G.,, J. L. Chason,, and M. Lerner. 1970. Augmentation of the virulence of murine coxsackie-virus B-3 myocardiopathy by exercise. J. Exp. Med. 131:11211136.
95. Gauntt, C. J.,, H. M. Arizpe,, A. L. Higdon,, M. M. Rozek,, R. Crawley,, and M. W. Cunningham. 1991. Anti-coxsackievirus B3 neutralizing antibodies with pathological potential. Eur. Heart J. Suppl. D 12:124129.
96. Gauntt, C. J.,, H. M. Arzipe,, J. T. Kung,, K. K. Ogilvie,, and U. O. Cheriyan. 1985. Antimyocarditic activity of the guanine derivative BIOLF-70 in a coxsackievirus B3 murine model. Antimicrob. Agents Chemother. 27:184191.
97. Gauntt, C. J.,, A. L. Higdon,, H. M. Arizpe,, M. R. Tamayo,, R. Crawley,, R. D. Henkel,, M. E. A. Pereira,, S. M. Tracy,, and M. W. Cunningham. 1993. Epitopes shared between coxsackievirus B3 (CVB3) and normal heart tissue contribute to CVB3-induced murine myocarditis. Clin. Immunol. Immunopathol. 68:129134.
98. Gauntt, C. J.,, A. Higdon,, D. Bowers,, E. Maull,, J. Wood,, and R. Crawley. 1993. What lessons can be learned from animal model studies in viral heart disease? Scand. J. Infect. Dis. Suppl. 88:4965.
99. Gauntt, C. J.,, W. C. Lutton,, E. K. Godeny,, S. M. Witherspoon,, H. M. Arizpe,, and R. E. Lanford. 1987. Murine coxsackie virus B3 myocarditis. Eur. Heart J. Suppl. J 8:393397.
100. Gelfand, H. M. 1961. The occurrence in nature of the coxsackie and ECHO viruses. Prog. Med. Virol. 3:193244.
101. Gifford, R.,, and G. Dalldorf. 1951. The morbid anatomy of experimental coxsackie virus infection. Am. J. Pathol. 27:10471056.
102. Gillespie, J. S.,, H. M. A. Cavanagh,, W. M. H. Behan,, L. J. A. Morrison,, F. McGarry,, and P. O. Behan. 1993. Increased transcription of interleukin-6 in the brains of mice with chronic enteroviral infection. J Gen. Virol. 74:741743.
103. Gobet, R.,, A. Cerny,, E. Ruedi,, H. Hengartner,, and R. M. Zinkernagel. 1988. The role of antibodies in natural and acquired resistance of mice to vesicular stomatitis virus. Exp. Cell. Biol. 56:175180.
104. Godeny, E. K.,, R. S. Cassling,, and C. J. Gauntt. 1987. Studies on the mechanism(s) of resistance to coxsackie virus B3 (CVB3)-in-duced myocarditis at adolescence in mice vaccinated at birth with a temperature-sensitive mutant of CVB3. Eur. Heart J. Suppl. J 8:403405.
105. Godeny, E. K.,, and C. J. Gauntt. 1986. Involvement of natural killer cells in coxsackievirus B3 viral-induced myocarditis. J. Immunol. 137:16951702.
106. Godeny, E. K.,, and C. J. Gauntt. 1987. Murine natural killer cells limit coxsackievirus B3 replication. J. Immunol. 139:913918.
107. Godeny, E. K.,, and C. J. Gauntt. 1987. Interferon and natural killer cell activity in coxsackie virus B3-induced murine myocarditis. Eur. Heart f. Suppl. J 8:433435.
108. Goodwin, J. F. 1987. Myocarditis and perimyocarditis. Histological survey, epidemiology and clinical features. Eur. Heart f. Suppl. J 8:79.
109. Goodwin, J. F. 1992. Cardiomyopathies and specific heart muscle diseases. Definitions, terminology, classifications and new and old approaches. Postgrad. Med. J. Suppl. I 68:S3S6.
110. Gore, I.,, and O. Saphir. 1947. Myocarditis. A classification of 1402 cases. Am. Heart J. 34:827830.
111. Goren, A.,, K. Kaplan,, J. Glaser,, and M. Isacsohn. 1989. Chronic neonatal coxsackie myocarditis. Arch. Dis. Child. 64:404406.
112. Goudevenos, J.,, G. Parry,, and R. G. Gold. 1990. Coxsackie B4 viral myocarditis causing ventricular aneurysm. Int. J. Cardiol. 27:122124.
113. Grasso, M.,, E. Arbustini,, E. Silini,, M. Diegoli,, E. Percivalle,, G. Ratti,, M. Bramerio,, A. Gavazzi,, M. Vigano,, and G. Milanesi. 1992. Search for coxsackievirus B3 RNA in idiopathic dilated cardiomyopathy using gene amplification by polymerase chain reaction. Am. J. Cardiol. 69:658664.
114. Gravanis, M. G.,, and N. H. Sternby. 1991. Incidence of myocarditis. Arch. Pathol. Lab. Med. 115:390392.
115. Greve, J. M.,, G. Davis,, A. M. Meyer,, C. P. Forte,, S. C. Yost,, C. W. Marlor,, M. E. Kamarck,, and A. McClelland. 1989. The major human rhinovirus receptor is ICAM-1. Cell 56:839847.
116. Grist, N. R. 1972. Viruses and myocarditis. Postgrad. Med. J. 48:750751.
117. Grist, N. R.,, and E. J. Bell. 1974. A six-year study of coxsackievirus B infections in heart disease. J. Hyg. Camb. 73:165172.
118. Grist, N. R.,, E. J. Bell,, and F. Assaad. 1978. Enteroviruses in human disease. Prog. Med. Virol. 24:114157.
119. Grodums, E. I.,, and G. Dempster. 1959. The age factor in experimental coxsackie B-3 infection. Can. J. Microbiol. 5:595604.
120. Grodums, E. I.,, and G. Dempster. 1959. Myocarditis in experimental coxsackie B-3 infection. Can. J. Microbiol. 5:605615.
121. Groenewegen, G.,, W. A. Buurman,, and C. J. van der Linden. 1985. Lymphokine dependence of in vivo expression of MHC class II antigens by endothelium. Nature (London) 316:361363.
122. Gudvangen, R. J.,, P. S. Duffey,, R. E. Paque,, and C. J. Gauntt. 1983. Levamisole exacerbates coxsackievirus B3-induced murine myocarditis. Infect. Immun. 41:11571165.
122a. Gulick, T.,, M. K. Chung,, S. J. Pieper,, L. G. Lange,, and G. F. Schreiner. 1989. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte β-adrenergic responsiveness. Proc. Natl. Acad. Sci. USA 86:67536757.
123. Gupta, S. C.,, H. Hengartner,, and R. M. Zinkernagel. 1986. Primary antibody responses to a well-defined and unique hapten are not enhanced by preimmunization with carrier: analysis in a viral model. Proc. Natl. Acad. Sci. USA 83:26042608.
124. Guthrie, M.,, P. A. Lodge,, and S. A. Huber. 1984. Cardiac injury in myocarditis induced by coxsackievirus group B, type 3 in Balb/c mice is mediated by Lyt 2+ cytolytic lymphocytes. Cell. Immunol. 88:558567.
125. Hammond, R. H.,, R. L. Menlove,, R. L. Yowell,, and J. L. Anderson. 1993. Vascular HLA-DR expression correlates with pathological changes suggestive of ischemia in idiopathic dilated cardiomyopathy. Clin. Immunol. Immunopathol. 68:197203.
126. Hauck, A. J.,, D. L. Kearney,, and W. D. Edwards. 1989. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for the role of sampling error. Mayo Clin. Proc. 64:12351245.
127. Heck, C. R.,, S. J. Shumway,, and M. R. Kaye. 1989. The registry of the international society for heart transplantation: sixth official report—1989. J. Heart Transplant. 8:271276.
128. Heikkila, J.,, and J. Karjalainen. 1982. Evaluation of mild acute infectious myocarditis. Br. Heart J. 47:381391.
129. Heim, A.,, A. Canu,, P. Kirschner,, T. Simon,, G. Mall,, P. H. Hofschneider,, and R. Kandolf. 1992. Synergistic interaction of interferon-p and interferon-y in coxsackievirus B3-infected carrier cultures of human myocardial fibroblasts. J. Infect. Dis. 166:958965.
130. Helin, M.,, J. Savola,, and K. Lapinleimu. 1968. Cardiac manifestations during a coxsackie B5 epidemic. Br. Med. J. 3:9799.
131. Hengstenberg, C.,, G. Hufnagel,, A. Haverich,, E. G. J. Olsen,, and B. Maisch. 1993. De novo expression of MHC class I and class II antigens on endomyocardial biopsies from patients with inflammatory heart disease and rejection following heart transplantation. Eur. Heart J. 14:758763.
132. Henke, A.,, C. Hohr,, H. Sprenger,, C. Graebner,, A. Stelzner,, M. Nain,, and D. Gemsa. 1992. Coxsackievirus B3-induced production of tumor necrosis factor-α, IL-lβ, and IL-6 in human monocytes. J. Immunol. 148:22702277.
133. Henke, A.,, M. Nain,, A. Stelzner,, and D. Gemsa. 1991. Induction of cytokine release from human monocytes by coxsackievirus infection. Eur. Heart J. Suppl. D 12:134136.
134. Henke, A.,, H.-P. Spengler,, A. Stelzner,, M. Nain,, and D. Gemsa. 1992. Lipopolysaccha-ride suppresses cytokine release from coxsackie virus-infected human monocytes. Res. Immunol. 143:6570.
135. Henry, Y.,, M. Lepoivre,, J. C. Drapier,, C. Ducrocq,, J. L. Boucher,, and A. Guissani. 1993. EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB J. 7:11241134.
136. Herzum, M.,, S. A. Huber,, R. Weller,, R. Grebe,, and B. Maisch. 1991. Treatment of experimental murine coxsackie B3 myocarditis. Eur. Heart J. Suppl D 12:200202.
137. Hess, A. D. 1993. Mechanisms of action of cyclosporine: considerations for the treatment of autoimmune diseases. Clin. Immunol. Immunopathol. 68:220228.
138. Hibbs, R. G.,, V. J. Ferrans,, W. C. Black,, J.J. Walsh,, and G. E. Burch. 1965.Viruslike particles in the heart of a patient with cardiomyopathy. Am. Heart J. 69:327337.
139. Hilton, D. A.,, S. Variend,, and J. H. Pringle. 1993. Demonstration of coxsackie virus RNA in formalin-fixed tissue sections from childhood myocarditis cases by in situ hybridization and the polymerase chain reaction. J. Pathol. 170:4551.
140. Hofschneider, P. H.,, K. Klingel,, and R. Kandolf. 1990. Toward understanding the pathogenesis of enterovirus-induced cardiomyopathy: molecular and ultrastructural approaches. J. Struct. Biol. 104:3237.
141. Hogle, J. M.,, M. Chow,, and D. J. Filman 1985. Three-dimensional structure of poliovirus at 2.9 A resolution. Science 229:13581365.
142. Hohenadl, C.,, K. Klingel,, J. Mertsching,, P. H. Hofschneider,, and R. Kandolf. 1991. Strand-specific detection of enteroviral RNA in myocardial tissue by in situ hybridization. Mol. Cell. Probes 5:1120.
143. Holland, J. J. 1961. Receptor affinities as major determinants of enterovirus tissue tropisms in humans. Virology 15:312326.
144. Homans, D. C. 1985. Current concepts. Peripartum cardiomyopathy. N. Engl. J. Med. 312:14321437.
145. Hosenpud, J. D.,, S. M. Campbell,, and D. J. Mendelson. 1989. Interleukin-1 induced myocardial depression in an isolated beating heart preparation. J. Heart Transplant. 8:460464.
146. Hosenpud, J. D.,, S. M. Campbell,, and G. Pan. 1990. Indirect inhibition of myocyte RNA and protein synthesis by interleukin-1. J. Mol. Cell. Cardiol. 22:213225.
147. Hosier, D. M.,, and W. A. Newton. 1958. Serious coxsackie infection in infants and children. Am. J. Dis. Child. 96:251267.
148. Hsu, K. H. L.,, and R. L. Crowell. 1989. Characterization of aYAC-1 mouse cell receptor for group B coxsackieviruses. J. Virol. 63:31053108.
149. Hsu, K. H. L.,, K. Lonberg-Holm,, B. Alstein,, and R. L. Crowell. 1988. A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses. J. Virol. 62:16471652.
150. Hsu, K. H. L.,, S. Paglini,, B. Alstein,, and R. L. Crowell,. 1990. Identification of a second cellular receptor for a coxsackievirus B3 variant, CB3-RD, p. 271277. In M. A. Brinton, and F. X. Heinz (ed.), New Aspects of Positive-Strand RNA Viruses. American Society for Microbiology, Washington D.C.
151. Huber, S. A. 1992. Heat-shock protein induction in adriamycin and picornavirus-infected cardiocytes. Lab. Invest. 67:218224.
152. Huber, S. A.,, C. Haisch,, and P. A. Lodge. 1990. Functional diversity in vascular endothelial cells: role in coxsackievirus tropism.J. Virol. 64:45164522.
153. Huber, S. A.,, N. Heintz,, and R. Tracy. 1988. Coxsackievirus B-3 induced myocarditis. Virus and actinomycin D treatment of myocytes induces novel antigens recognized by cytolyticT lymphocytes. J. Immunol. 141:32143219.
154. Huber, S. A.,, and L. P. Job. 1983. Differences in cytolytic T cell response of BALB/c mice infected with myocarditic and non-myocarditic strains of coxsackievirus group B, type 3. Infect. Immun. 39:14191427.
155. Huber, S. A.,, L. P. Job,, and K. R. Auld. 1982. Influence of sex hormones on coxsackie B-3 virus infection in Balb/c mice. Cell. Immunol. 67:173189.
156. Huber, S. A.,, L. P. Job,, K. R. Auld,, and J. F. Woodruff. 1981. Sex-related differences in the rapid production of cytotoxic spleen cells active against uninfected myofibers during coxsackievirus B-3 infection. J. Immunol. 126:13361340.
157. Huber, S. A.,, L. P. Job,, and J. F. Woodruff. 1980. Lysis of infected myofibers by coxsackievirus B-3-immune T lymphocytes. Am. J. Pathol. 98:681694.
158. Huber, S. A.,, L. P. Job,, and J. F. Woodruff. 1981. Sex-related differences in the pattern of coxsackievirus B-3-induced immune spleen cell cytotoxicity against virus-infected myofibers. Infect. Immun. 32:6873.
159. Huber, S. A.,, L. P. Job,, and J. F. Woodruff. 1984. In vitro culture of coxsackievirus group B, type 3 immune spleen cells on infected endothelial cells and biological activity of cultured cells in vivo. Infect. Immun. 43:567573.
160. Huber, S. A.,, and P. A. Lodge. 1984. Coxsackievirus B-3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens. Am. J. Pathol. 116:2129.
161. Huber, S. A.,, and P. A. Lodge. 1986. Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/ 2 and Balb/c mice. Am. J. Pathol. 122:284291.
162. Huber, S. A.,, J. Polgar,, P. Schultheiss,, and P. Schwimmbeck. 1994. Augmentation of pathogenesis of coxsackievirus B3 infection in mice by exogenous administration of IL-1 and IL-2.J. Virol. 68:195206.
163. Hufnagel, G.,, and B. Maisch. 1991. Expression of MHC class I and II antigens and the 11-2 receptor in rejection, myocarditis and dilated cardiomyopathy. Eur. Heart. J. Suppl. D 12:137140.
164. Hyypia, T.,, M. Kallajoki,, M. Maaronen,, G. Stanway,, R. Kandolf,, P. Auvinen,, and H. Kalimo. 1993. Pathogenetic differences between coxsackie A and B virus infections in newborn mice. Virus Res. 27:7178.
165. Ilback, N.-G.,, J. Fohlman,, and G. Friman. 1989. Exercise in coxsackie B3 myocarditis: effects on heart lymphocyte sub-populations and the inflammatory reaction. Am. Heart J. 117:12981302.
166. Ilback, N.-G.,, J. Fohlman,, and G. Friman. 1993. Altered distribution of heavy metals and lipids in coxsackievirus B3 infected mice. Scand.J. Infect. Dis. Suppl. 88:9398.
167. Ilback, N.-G.,, J. Fohlman,, S. Slorach,, and G. Friman. 1989. Effects of the immunomodulator LS 2616 on lymphocyte subpopulations in murine coxsackievirus B3 myocarditis. J. Immunol. 142:32253228.
168. Ilback, N.-G.,, A. Mohammed,, J. Fohlman,, and G. Friman. 1990. Cardiovascular lipid accumulation with coxsackie B virus infection in mice. Am. J. Pathol. 136:159167.
169. Ilback, N.-G.,, L. Wesslen,, K. Pauksen,, T. Stalhandske,, G. Friman,, and J. Fohlman. 1993. Effects of the antiviral WIN 54954 and the immune modulator LS 2616 on cachectin/ TNF and y-interferon responses during viral heart disease. Scand. J. Infect. Dis. Suppl. 88:117123.
170. Jin, O.,, M. J. Sole,, J. W. Butany,, W.-K. Chia,, P. R. McLaughlin,, P. Liu,, and C.-C. Liew. 1990. Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation 82:816.
171. Job, L. P.,, D. C. Lyden,, and S. A. Huber. 1986. Demonstration of suppressor cells in coxsackievirus group B, type 3 infected female Balb/c mice which prevent myocarditis. Cell. Immunol. 98:104113.
172. Jubelt, B.,, A. K. Wilson,, S. L. Ropka,, P. L. Guidinger,, and M. A. McKinlay. 1989. Clearance of a persistent human enterovirus infection of the mouse central nervous system by the antiviral agent disoxaril.J. Infect. Dis. 159:866871.
173. Julian, D. G.,, and P. Szekely. 1985. Peripartum cardiomyopathy. Prog. Cardiovasc. Dis. 27:223240.
174. Kamijo, R.,, H. Harada,, T. Matsuyama,, M. Bosland,, J. Gerecitano,, D. Shapiro,, J. Le,, S. I. Koh,, T. Kimura,, S. J. Green,, T. W. Mak,, T. Taniguchi,, and J. Vilcek. 1994. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263:16121615.
175. Kandolf, R., 1988. The impact of recombinant DNA technology on the study of enterovirus heart disease, p. 293318. In M. Bendinelli, and H. Friedman (ed.), Coxsackieviruses: a General Update. Plenum Press, New York.
176. Kandolf, R.,, D. Ameis,, P. Kirschner,, A. Canu,, and P. H. Hofschneider. 1987. In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc. Natl. Acad. Sci. USA 84:62726276.
177. Kandolf, R.,, A. Canu,, and P. H. Hofschneider. 1985. Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon. J. Mol. Cell. Cardiol. 17:167181.
178. Kandolf, R.,, A. Canu,, K. Klingel,, P. Kirschner,, H. Schdnke,, J. Mertsching,, R. Zell,, and P. H. Hofschneider,. 1990. Molecular studies on enteroviral heart disease, p. 340348. In M. A. Brinton, and F. X. Heinz (ed.), New Aspects of Positive-Strand RNA Viruses. American Society for Microbiology, Washington D.C.
179. Kandolf, R.,, and P. H. Hofschneider. 1989. Enteroviral heart disease. Springer Semin. Immunopathol. 11:113.
180. Kandolf, R.,, P. Kirschner,, D. Ameis,, A. Canu,, and P. H. Hofschneider. 1987. Cultured human heart cells: a model system for the study of the antiviral activity of interferons. Eur. Heart J. Suppl. J 8:453456.
181. Kandolf, R.,, K. Klingel,, H. Mertsching,, A. Canu,, C. Hohenadl,, R. Zell,, B. Y. Reimann,, A. Heim,, B. M. McManus,, A. K. Foulis,, H. P. Schultheiss,, E. Erdmann,, and G. Riecker. 1991. Molecular studies on enteroviral heart disease: patterns of acute and persistent infections. Eur. Heart J. Suppl. D 12:4955.
182. Kandolf, R.,, K. Klingel,, R. Zell,, A. Canu,, U. Fortmuller,, C. Hohenadl,, M. Albrecht,, B.-Y. Reimann,, W. M. Franz,, A. Heim,, U. Raab,, and F. McPhee. 1993. Molecular mechanisms in the pathogenesis of enteroviral heart disease: acute and persistent infections. Clin. Immunol. Immunopathol. 68:153158.
183. Kaplan, M. H.,, S. W. Klein,, J. McPhee,, and R. G. Harper. 1983. Group B coxsackievirus infections in infants younger than three months of age: a serious childhood illness. Rev. Infect. Dis. 5:10191032.
184. Karjalainen, J. 1993. Clinical diagnosis of myocarditis and dilated cardiomyopathy. Scand. J. Infect. Dis. Suppl. 88:3343.
185. Karjalainen, J.,, and J. Heikkila. 1986. "Acute pericarditis": myocardial enzyme release as evidence for myocarditis. Am. Heart J. 111:546552.
186. Karjalainen, J.,, J. Heikkila,, M. S. Nieminen,, H. Jalanko,, M. Kleemola,, K. Lapinleimu,, and T. Sahi. 1983. Etiology of mild acute infectious myocarditis. Relation to clinical features. Acta Med. Scand. 213:6573.
187. Karupiah, G.,, Q.-W. Xie,, R. M. L. Buller,, C. Nathan,, C. Duarte,, and J. D. MacMicking. 1993. Inhibition of viral replication by interferon-y-induced nitric oxide synthase. Science 261:14451448.
188. Kasai, M.,, D. M. Iwamori,, Y. Nagai,, K. Okumura,, and T. Tada. 1980. A glycolipid on the surface of mouse natural killer cells. Eur. J. Immunol. 10:175180.
189. Kawai, C. 1971. Idiopathic cardiomyopathy. A study on the infectious-immune theory as a cause of the disease. Jpn. Circ.J. 35:765770.
190. Kawai, C.,, A. Matsumori,, Y. Kitaura,, and T. Takatsu. 1978. Viruses and the heart: viral myocarditis and cardiomyopathy. Prog. Cardiol. 7:141162.
191. Kawai, C.,, and T. Takatsu. 1975. Clinical and experimental studies on cardiomyopathy. N. Engl. J. Med. 293:592597.
192. Keeling, P. J.,, S. Jeffery,, A. Caforio,, R. Taylor,, G. F. Bottazzo,, M. J. Davies,, and W. J. McKenna. 1992. Similar prevalence of enteroviral genome within the myocardium from patients with idiopathic dilated cardiomyopathy and controls by the polymerase chain reaction. Br. Heart J. 68:554559.
193. Keren, A.,, and R. L. Popp. 1992. Assignment of patients into the classification of cardiomyopathies. Circulation 86:16221633.
194. Kilbourne, E. D.,, and F. L. Horsfall, Jr. 1951. Lethal infection with coxsackie virus of adult mice given cortisone. Proc. Soc. Exp. Biol. Med. 77:135138.
195. Kilbourne, E. D.,, C. B. Wilson,, and D. Perrier. 1956. The induction of gross myocardial lesions by a coxsackie (pleurodynia) virus and cortisone. J. Clin. Invest. 35:362370.
196. Kishimoto, C.,, K. A. Thorp,, and W. H. Abelmann. 1990. Immunosuppression with high doses of cyclophosphamide reduces the severity of myocarditis but increases the mortality in murine coxsackievirus B3 myocarditis. Circulation 82:982989.
197. Kitaura, Y. 1981. Virological study of idiopathic cardiomyopathy; serological study of virus antibodies and immunofluorescent study of myocardial biopsies. Jpn. Circ.J. 45:279294.
198. Klein, J. O.,, and J. S. Remington,. 1990. Current concepts on infections of the fetus and newborn infant, p. 116. In J. S. Remington, and J. O. Klein (ed.), Infectious Diseases of the Fetus and Newborn Infant. The W. B. Saunders Co., Philadelphia.
199. Klingel, K.,, C. Hohenadl,, A. Canu,, M. Albrecht,, M. Seemann,, G. Mall,, and R. Kandolf. 1992. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc. Natl. Acad. Sci. USA 89:314318.
200. Klingel, K.,, and R. Kandolf. 1993 The role of enterovirus replication in the development of acute and chronic heart muscle disease in different immunocompetent mouse strains. Scand. J. Infect. Dis. Suppl. 88:7985.
201. Klump, W. M.,, I. Bergmann,, B. C. Miiller,, D. Ameis,, and R. Kandolf. 1990. Complete nucleotide sequence of infectious coxsackievirus B3 cDNA: two initial 5' uridine residues are regained during plus-strand RNA synthesis. J. Virol. 64:15731583.
202.Koberle, E 1957. Die chronische Chagaskardiopathie. Virchows Arch. 330:267295.
203. Koide, H.,, Y. Kitaura,, H. Deguchi,, A. Ukimura,, K. Kawamura,, and K. Hirai. 1992. Genomic detection of enteroviruses in the myocardium. Studies on animal hearts with coxsackievirus B3 myocarditis and endomyocardial biopsies from patients with myocarditis and dilated cardiomyopathy. Jpn. Circ. J. 56:10811093.
204. Kuhl, U.,, M. Noutsias,, B. Seeberg,, M. Schannwell,, L. B. Welp,, H. P. Schultheiss,, and B. E. Strauer. 1994. Chronic inflammation in dilated cardiomyopathy. Heart Failure 9:231245.
205. Kyu, B.-S.,, A. Matsumori,, Y. Sato,, I. Okada,, N. M. Chapman,, and S. Tracy. 1992. Cardiac persistence of cardioviral RNA detected by polymerase chain reaction in a murine model of dilated cardiomyopathy. Circulation 86:522530.
206. Landau, B. J.,, P. S. Whittier,, S. D. Finkelstein,, B. Alstein,, J. B. Grun,, M. Schultz,, and R. L. Crowell. 1990. Induction of heterotypic virus resistance in adult inbred mice immunized with a variant of coxsackievirus B3. Microb. Pathog. 8:289298.
207. Lane, J. R.,, D. A. Neumann,, A. Lafond-Walker,, A. Herskowitz,, and N. R. Rose. 1992. Interleukin 1 or tumor necrosis factor can promote coxsackie B3-induced myocarditis in resistant BIO.A mice. J. Exp. Med. 175:11231129.
208. Lane, J. R.,, D. A. Neumann,, A. Lafond-Walker,, A. Herskowitz,, and N. R. Rose. 1993. Role of IL-1 and tumor necrosis factor in coxsackie virus-induced autoimmune myocarditis. J. Immunol. 151:16821690.
209. Leist, T. P.,, S. P. Cobbold,, H. Waldmann,, M. Aguet,, and R. M. Zinkernagel. 1987. Functional analysis of T lymphocyte subsets in antiviral host defense. J. Immunol. 138:22782281.
210. Lerner, A. M. 1965. An experimental approach to virus myocarditis. Prog. Med. Virol. 7:97115.
211. Lerner, A. M.,, H. S. Levin,, and M. Finland. 1962. Age and susceptibility of mice to coxsackie A viruses. J. Exp. Med. 115:745762.
212. Lerner, A. M.,, and J. A. Shaka. 1962. Coxsackie A9 myocarditis in adult mice. Proc. Soc. Exp. Biol. Med. 111:804808.
213. Leslie, K.,, R. Blay,, C. Haisch,, A. Lodge,, A. Weller,, and S. Huber. 1989. Clinical and experimental aspects of viral myocarditis. Clin. Microbiol. Rev. 2:191203.
214. Leslie, K. O.,, J. Schwarz,, K. Simpson,, and S. A. Huber. 1990. Progressive interstitial collagen deposition in coxsackievirus B3-in-duced murine myocarditis. Am. J. Pathol. 136:683693.
215. Leung, D. Y. M.,, R. S. Geha,, J. W. Newburger,, J. C. Burns,, W. Fiers,, L. A. Lapierre,, and J. S. Pober. 1986. Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J. Exp. Med. 164:19581972.
216. Levander-Lindgren, M. 1965. Studies in myocarditis. IV. Late prognosis. Cardiologia 47:209220.
217. Levi, G.,, S. Scalvini,, M. Volterrani,, S. Marangoni,, G. Arosio,, and A. Quadri. 1988. Coxsackie virus heart disease; 15 years after. Eur. Heart J. 9:13031307.
218. Lieberman, E. B.,, A. Herskowitz,, N. R. Rose,, and K. L. Baughman. 1993. A clinicopathologic description of myocarditis. Clin. Immunol. Immunopathol. 68:191196.
219. Lieberman, E. B.,, G. M. Hutchins,, A. Herskowitz,, N. R. Rose,, and K. L. Baughman. 1991. Clinicopathologic description of myocarditis. J. Am. Coll. Cardiol. 18:16171626.